StockWireNews
Could This Nasdaq Biotech Be Ready To Crush Breast And Ovarian Cancers? Take Notice Now (5 Straight Champs!)
Full Report Arrives At 8:00PM EST Tonight Or 9:30AM EST Tomorrow
*Sign Up To My Telegram Channel - Directions Below*
January 15th
Greetings Readers,
A new multi-month high? A double-digit intraday surge?
That's what happened this past Thursday with my latest breakout alert.
Erupting from a $2.18 open to a $2.67 high, the Nasdaq tech profile put together a scorching hot move of approx. 22% intraday.
Solid stuff, but it gets even better when you realize that was our 5th straight champ in a row!
With recent runners of approximately 19%, 19%, 95%, and 39%, this streak has been bringing the heat all winter while everyone has been freezing their butts off!
Ready to turn it up a few degrees?
At 8:00PM EST tonight or 9:30AM EST tomorrow, that very well could happen when a new report hits your desk.
And when it comes to red hot technicals, this breakout idea has got them.
With at least 10 triggered across the short, medium, and long term over at Barchart, this moderately low float (under 30Mn shares) profile is starting to turn heads.
But that's not all...
Specializing in immunotherapy treatments for breast and ovarian cancers, this biotech company recently announced positive results from a Phase 1 clinical trial of its breast cancer vaccine.
Are you ready to get this company on your radar before everyone else? Tune in at 8:00PM EST tonight or 9:30AM EST tomorrow for the full report.
Also, do this:
#1. Join my Telegram channel to receive my alerts on the fly. Click here.
#2. Follow these instructions: